Abstract
Diabetes mellitus is a chronic disease that affects millions of people around the world. One of the medicinal plants used by the Brazilian population in the treatment of diabetes mellitus is Bauhinia forficata Link. The objective of this work was to conduct a review of clinical case studies in order to analyze the hypoglycemic effect of B. forficata infusion in diabetic and pre-diabetic individuals. A direct search for articles of clinical cases was carried out in the databases LILACS, PubMed, SciELO, and Scopus. Were searched works in Spanish, English and Portuguese, published in the last 10 years and that only used the infusion of leaves of the plant species in the treatment of mens and womens, over the age of 18, with pre-diabetes or diabetes mellitus. Were used the keywords "Bauhinia forficata" and "diabetes", and the boolean operator “AND”. Five studies were found, of which three of them presented positive results in relation to the use of B. forficata infusion as an effective hypoglycemic agent in diabetic and pre-diabetic individuals, while two studies did not present positive results. It was concluded that the infusion of B. forficata is able to assist in the treatment of diabetes mellitus, despite the need for more scientific evidence on the subject.
Highlights
Diabetes mellitus (DM) consists of a chronic non-transmissible disease characterized by excess glucose in the blood, due to deficient production of insulin by the pancreas or resistance to its action on tissues (Sociedade Brasileira de Diabetes, 2019).This metabolic disorder reaches epidemic proportions
One of the medicinal plants used by the Brazilian population in the treatment of diabetes mellitus is Bauhinia forficata Link
The objective of this work was to conduct a review of clinical case studies in order to analyze the hypoglycemic effect of B. forficata infusion in diabetic and pre-diabetic individuals
Summary
Diabetes mellitus (DM) consists of a chronic non-transmissible disease characterized by excess glucose in the blood, due to deficient production of insulin by the pancreas or resistance to its action on tissues (Sociedade Brasileira de Diabetes, 2019). DM 1 is an autoimmune, polygenic disease, resulting from the destruction of pancreatic beta cells, causing complete deficiency of insulin synthesis (Chiang, Kirkman, Laffel & Peters, 2014; Insel et al, 2015) and corresponds to 5-10% of all cases of DM. It is most often diagnosed in children and adolescents, less common in adults. Gestational diabetes mellitus (GDM) is usually diagnosed in women who are in the second or third trimester of pregnancy, and can be associated with both insulin resistance and beta-pancreatic cell dysfunction, which can cause risks for both the mother and the fetus.
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.